0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Erythrodermic Epidermolysis Bullosa Acquisita FREE

Stefanie Häfliger, MD1; Hans-Wilhelm Klötgen, MD1; Michael Horn, PhD2; Helmut Beltraminelli, MD1; Luca Borradori, MD1
[+] Author Affiliations
1Department of Dermatology, University of Berne, Inselspital, Berne, Switzerland
2Department of Immunology, University of Berne, Inselspital, Berne, Switzerland
JAMA Dermatol. 2015;151(6):678-680. doi:10.1001/jamadermatol.2015.31.
Text Size: A A A
Published online

Epidermolysis bullosa acquisita (EBA) is a rare acquired subepidermal blistering autoimmune disease of the skin and mucosae associated with autoantibodies directed against type VII collagen, the major component of the anchoring fibrils of the dermal-epidermal junction.1,2 Various clinical presentations of EBA have been described, including a noninflammatory mechanobullous form, an inflammatory bullous pemphigoid (BP)-like form, and a mucous-membrane pemphigoid-like form. These forms may show clinical overlap, and their courses are often unpredictable.13

REPORT OF A CASE

A 60-year-old man was admitted for evaluation of a 3-week history of widespread pruritic cutaneous lesions. The patient had taken no drugs, and his medical history was unremarkable. On examination, almost his entire trunk, buttocks, and thighs were erythematous and infiltrated with papular and urticarial lesions (Figure 1). Islands of normal-appearing skin were observed. On his soles and palms, isolated lesions with a targetlike appearance were noted. The head as well as the oral and genital mucous membranes were spared. During hospital admission, the patient developed isolated vesicles and serous blisters on erythematous skin on his wrist and ankle.

Place holder to copy figure label and caption
Figure 1.
Clinical Appearance of Erythrodermic Epidermolysis Bullosa Acquisita

The patient has generalized erythematous confluent papular and urticarial lesions on the trunk.

Graphic Jump Location

Light microscopy studies of a skin biopsy specimen obtained from patient’s back showed a diffuse spongiosis with a mixed perivascular inflammatory infiltrate consisting of eosinophils and neutrophils in the upper dermis (Figure 2). Direct immunofluorescence microscopy studies disclosed linear deposits of IgG and C3 along the epidermal basement membrane zone. By indirect immunofluorescence microscopy using sodium chloride–separated normal human skin, circulating IgG autoantibodies binding the dermal side of the split were detected.

Place holder to copy figure label and caption
Figure 2.
Light Microscopy Study of a Skin Biopsy Specimen From Patient’s Back

Specimen shows epidermal spongiosis with a mixed perivascular inflammatory infiltrate composed of eosinophils and neutrophils in the upper dermis (hematoxylin-eosin, original magnification ×40).

Graphic Jump Location

Immunoblotting analysis using human dermal extracts showed a reactivity with a 290-kDa protein showing the same electrophoretic migration to the protein band recognized by the control monoclonal antibody directed against type VII collagen.

Based on the clinical features and immunopathological findings, the diagnosis of EBA was made.1 The patient was given oral prednisolone, 0.75 mg/kg of body weight, which resulted in rapid clearance of the lesions within 2 weeks. Corticosteroid doses were subsequently slowly tapered. At a dose of 10 mg/d, the patient experienced a relapse and began treatment with methotrexate, 15 mg subcutaneously once weekly. The prednisolone dose was then tapered to 2.5 mg/d, and the patient remained asymptomatic at 6-month follow-up.

DISCUSSION

The clinical features of EBA are protean. The classic presentation is that of a noninflammatory mechanobullous disease characterized by the development of acral blisters that heal with atrophic scarring, milia, and hyperpigmentation or hypopigmentation. They are localized to trauma-prone surfaces such as elbows, knees, hands, and feet.13 Acral involvement may be mutilating. Scalp involvement occurs in up to 20% of patients.13 The inflammatory BP-like presentation is associated with widespread vesicles and bullae involving intertriginous and flexural areas that heal without atrophic scarring.13 Epidermolysis bullosa acquisita may also present as mucous membrane pemphigoid or as Brunsting-Perry pemphigoid phenotype.3 The potential causes of erythroderma include psoriasis, atopic dermatitis, drug reactions, and cutaneous T-cell lymphoma. With the exception of pemphigus foliaceus, the other autoimmune bullous diseases of the skin have been only anecdotally implicated as cause of erythroderma. Specifically, single cases of erythrodermic BP have been described.4,5 Epidermolysis bullosa acquisita is potentially associated with a number of systemic diseases, including inflammatory bowel diseases,1,3 but our patient showed no evidence of any of these.

Our case was striking because the patient initially showed features suggestive of either a severe drug reaction or a paraviral eruption, but immunopathological studies were diagnostic for EBA. Our observation provides a further example about the polymorphous and misleading presentations of EBA. Hence, EBA should be considered as a rare cause of erythroderma.

ARTICLE INFORMATION

Corresponding Author: Stefanie Häfliger, MD, Universitätsklinik für Dermatologie, Inselspital, 3010 Bern, Schweiz (stefanie.haefliger@insel.ch).

Published Online: March 18, 2015. doi:10.1001/jamadermatol.2015.31.

Conflict of Interest Disclosures: None reported.

Additional Contributions: The authors are indebted to Lionel Fontao, PhD, Department of Dermatology, University of Geneva, for performing the search of anti–type VII collagen antibodies by immunoblotting studies.

REFERENCES

Gammon  WR, Briggaman  RA.  Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus: diseases of autoimmunity to type VII collagen. Dermatol Clin. 1993;11(3):535-547.
PubMed
Woodley  DT, Chang  C, Saadat  P, Ram  R, Liu  Z, Chen  M.  Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol. 2005;124(5):958-964.
PubMed   |  Link to Article
Borradori  L, Bernard  P. Pemphigoid group. In: Bolognia  JL, Jorizzo  JL, Schaffer  JV, eds. Dermatology. 3rd ed. New York, NY: Elsevier; 2012:431-445.
Korman  NJ, Woods  SG.  Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid. Br J Dermatol. 1995;133(6):967-971.
PubMed   |  Link to Article
Amato  L, Gallerani  I, Mei  S, Pestelli  E, Caproni  M, Fabbri  P.  Erythrodermic bullous pemphigoid. Int J Dermatol. 2001;40(5):343-346.
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.
Clinical Appearance of Erythrodermic Epidermolysis Bullosa Acquisita

The patient has generalized erythematous confluent papular and urticarial lesions on the trunk.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Light Microscopy Study of a Skin Biopsy Specimen From Patient’s Back

Specimen shows epidermal spongiosis with a mixed perivascular inflammatory infiltrate composed of eosinophils and neutrophils in the upper dermis (hematoxylin-eosin, original magnification ×40).

Graphic Jump Location

Tables

References

Gammon  WR, Briggaman  RA.  Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus: diseases of autoimmunity to type VII collagen. Dermatol Clin. 1993;11(3):535-547.
PubMed
Woodley  DT, Chang  C, Saadat  P, Ram  R, Liu  Z, Chen  M.  Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol. 2005;124(5):958-964.
PubMed   |  Link to Article
Borradori  L, Bernard  P. Pemphigoid group. In: Bolognia  JL, Jorizzo  JL, Schaffer  JV, eds. Dermatology. 3rd ed. New York, NY: Elsevier; 2012:431-445.
Korman  NJ, Woods  SG.  Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid. Br J Dermatol. 1995;133(6):967-971.
PubMed   |  Link to Article
Amato  L, Gallerani  I, Mei  S, Pestelli  E, Caproni  M, Fabbri  P.  Erythrodermic bullous pemphigoid. Int J Dermatol. 2001;40(5):343-346.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

595 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs